New directions in our patent portfolio
The updated portfolio includes a published arthritis application and a breast cancer application.
Home / Company news
Company newsMilestones in our journey.
Selected developments in research, intellectual property and commercial activity.
US Patent 9,603,965 granted
System and method for delivering protease inhibitors, granted March 28, 2017.
Research and development milestones
Manufacturing licensing milestones in India, participation in the World Ayurveda Congress, and a presentation at the ACS National Meeting.
Tissue engineering research presentations
Scientific presentations at the Symposium on Biologic Scaffolds for Regenerative Medicine and TERMIS-AM.